NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia · Delayed Price · Currency is AUD 0.0590
-0.0030 (-4.84%)
Aug 5, 2026, 4:10 PM AEST
ASX:NSB Market Cap
ASX:NSB has a market cap or net worth of 24.16 million as of August 5, 2026. Its market cap has decreased by -68.41% in one year.
Market Cap
24.16M
Enterprise Value
17.81M
Revenue
317.91K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
ChartMarket Cap Chart
Since July 27, 2018, ASX:NSB's market cap has increased from 16.56M to 24.16M, an increase of 45.95%. That is a compound annual growth rate of 4.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 22.99M | -37.15% |
| Dec 31, 2025 | 36.58M | 666.63% |
| Dec 30, 2024 | 4.77M | -25.00% |
| Dec 29, 2023 | 6.36M | -64.52% |
| Dec 29, 2022 | 17.93M | -62.69% |
| Dec 31, 2021 | 48.06M | 116.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurizon Therapeutics | 46.27M |
| Imugene | 34.93M |
| Algorae Pharmaceuticals | 24.31M |
| Noxopharm | 24.27M |
| Proteomics International Laboratories | 22.30M |
| Patrys | 22.00M |
| EZZ Life Science Holdings | 21.89M |
| Neurotech International | 21.08M |